These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26160883)

  • 21. Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research.
    Fouad MN; Partridge E; Wynn T; Green BL; Kohler C; Nagy S
    Cancer; 2001 Jan; 91(1 Suppl):237-41. PubMed ID: 11148586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study.
    Mc Grath-Lone L; Day S; Schoenborn C; Ward H
    BMC Cancer; 2015 Sep; 15():618. PubMed ID: 26341736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.
    Moorcraft SY; Marriott C; Peckitt C; Cunningham D; Chau I; Starling N; Watkins D; Rao S
    Trials; 2016 Jan; 17():17. PubMed ID: 26745891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial Disparities in Differentiated Thyroid Cancer: Have We Bridged the Gap?
    Shah SA; Adam MA; Thomas SM; Scheri RP; Stang MT; Sosa JA; Roman SA
    Thyroid; 2017 Jun; 27(6):762-772. PubMed ID: 28294040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public attitudes toward participation in cancer clinical trials.
    Comis RL; Miller JD; Aldigé CR; Krebs L; Stoval E
    J Clin Oncol; 2003 Mar; 21(5):830-5. PubMed ID: 12610181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
    Dilts DM; Sandler AB; Baker M; Cheng SK; George SL; Karas KS; McGuire S; Menon GS; Reusch J; Sawyer D; Scoggins M; Wu A; Zhou K; Schilsky RL;
    J Clin Oncol; 2006 Oct; 24(28):4553-7. PubMed ID: 17008694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of older patients with prostate cancer in Medicare eligible trials.
    Craig BM; Gilbert SM; Herndon JB; Vogel B; Quinn GP
    J Urol; 2010 Sep; 184(3):901-6. PubMed ID: 20643449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with non-participation and dropout among cancer patients in a cluster-randomised controlled trial.
    Roick J; Danker H; Kersting A; Briest S; Dietrich A; Dietz A; Einenkel J; Papsdorf K; Lordick F; Meixensberger J; Mössner J; Niederwieser D; Prietzel T; Schiefke F; Stolzenburg JU; Wirtz H; Singer S
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28134477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials.
    Housri N; Khan AJ; Taunk N; Goyal S; Nelson CJ; Ferro A; Haffty BG
    Breast J; 2015; 21(4):387-94. PubMed ID: 25919123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
    Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB
    J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
    Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
    Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation bias assessment in a community-based study of myocardial infarction, 2002-2005.
    Gerber Y; Jacobsen SJ; Killian JM; Weston SA; Roger VL
    Mayo Clin Proc; 2007 Aug; 82(8):933-8. PubMed ID: 17673061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient participation in medical consultations: why some patients are more involved than others.
    Street RL; Gordon HS; Ward MM; Krupat E; Kravitz RL
    Med Care; 2005 Oct; 43(10):960-9. PubMed ID: 16166865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
    McKillip RP; Borden BA; Galecki P; Ham SA; Patrick-Miller L; Hall JP; Hussain S; Danahey K; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Ratain MJ; Meltzer DO; O'Donnell PH
    Clin Pharmacol Ther; 2017 Jul; 102(1):106-114. PubMed ID: 27981566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarction.
    Parashar S; Spertus JA; Tang F; Bishop KL; Vaccarino V; Jackson CF; Boyden TF; Sperling L
    Circulation; 2012 Sep; 126(13):1587-95. PubMed ID: 22929302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing.
    Cuffe S; Hon H; Qiu X; Tobros K; Wong CK; De Souza B; McFarlane G; Masroor S; Azad AK; Hasani E; Rozanec N; Leighl N; Alibhai S; Xu W; Issa AM; Liu G
    Pharmacogenet Genomics; 2014 Jul; 24(7):348-55. PubMed ID: 24911662
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.